Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma
Clinical trial NCT06676293 · COMPLETED
Trial details
- NCT number
- NCT06676293
- Sponsor
- Chang Gung Memorial Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-04-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.